Company attributes
Location
B2X
Parent Organization
Number of Employees (Ranges)
1 – 10
Email Address
roche.venturefund@roche.com
Investors
Founded Date
2002
Competitors
Key People
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Roche Venture Fund is a Basel, Switzerland based venture capital fund of Roche Holding founded in 2002.
The firm seeks to invest in life science companies in the pharmaceuticals and diagnostics sectors. The firm invests in early-stage and growth stages.
The notable investment portfolio of Roche Venture Fund includes Arch Oncology, Entrada Therapeutics, Freenome, Good Therapeutics, Jasper Therapeutics, MacuLogix, Minoryx Therapeutics, Biodesy, Purigen Biosystems, and Second Genome, etc.
As of January 2020, Roche Venture Fund has made 129 investments and had 67 exits.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Associated Investment Funds
Accelerator Batches
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
